BamSEC and AlphaSense Join Forces
Learn More

Alkermes plc – Material Contracts

NASDAQ: ALKS    
Share price (9/29/26): $40.80    
Market cap (9/29/26): $6.845 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 15 pages Alkermes plc 2018 Stock Option and Incentive Plan, as Amended
12/34/56
EX-10.2
from 10-Q 6 pages February 24, 2026 Richard F. Pops Connaught House, 1 Burlington Road Dublin 4, Ireland D04 C5y6
12/34/56
EX-10.24
from 10-K 16 pages Alkermes plc 2018 Stock Option and Incentive Plan, as Amended
12/34/56
EX-10.3
from 10-Q 4 pages Material contract
12/34/56
EX-10.1
from 10-Q 61 pages Confidential Authorized Generic Product Supply Agreement Amneal Pharmaceuticals LLC, – And – Alkermes Pharma Ireland Limited Dated as of September 9, 2025
12/34/56
EX-10.1
from 8-K 15 pages Alkermes plc 2018 Stock Option and Incentive Plan, as Amended
12/34/56
EX-10.2B
from 10-Q 3 pages 2018 Plan Award Certificate - Non-Employee Director Restricted Stock Unit (Time-Vesting) Alkermes plc Connaught House 1 Burlington Road Dublin 4, Ireland Name: Participant Name Address: Participant Address Grant Id: Grant Id Plan: Plan Id Id: Grantee Id
12/34/56
EX-10.2A
from 10-Q 3 pages 2018 Plan Award Certificate - Non-Employee Director Non-Qualified Stock Option Alkermes plc Connaught House 1 Burlington Road Dublin 4, Ireland Name: Participant Name Address: Participant Address Grant Id: Grant Id Plan: Plan Id Id: Optionee Id
12/34/56
EX-10.1
from 10-Q 4 pages Fifth Amendment to License and Collaboration Agreement
12/34/56
EX-10.1
from 8-K 15 pages Alkermes plc 2018 Stock Option and Incentive Plan, as Amended
12/34/56
EX-10.5A
from 10-K 13 pages Portions of This Exhibit (Indicated by “[**]”) Have Been Omitted Pursuant to Item 601(b)(10)(iv) of Regulation S-K. Schedules and Similar Attachments to This Exhibit Have Been Omitted Pursuant to Item 601(a)(5) of Regulation S-K. Third Amendment to Development and License Agreement
12/34/56
EX-10.25N
from 10-K 4 pages 2018 Plan Award Certificate – Restricted Stock Unit (Performance-Vesting)_(rev. 2024) Alkermes plc Connaught House 1 Burlington Road Dublin 4, Ireland Name: Participant Name Address: Participant Address Grant Id: Grant Id Plan: Plan Id Id: Grantee Id
12/34/56
EX-10.25M
from 10-K 4 pages 2018 Plan Award Certificate –Performance-Vesting Restricted Stock Unit Award (Reporting Officer)_(rev. 2024) Alkermes plc Connaught House 1 Burlington Road Dublin 4, Ireland Name: Participant Name Address: Participant Address Grant Id: Grant Id Plan: Plan Id Id: Optionee Id
12/34/56
EX-10.13A
from 10-K 4 pages Amendment to Employee Matters Agreement
12/34/56
EX-10.16
from 10-K 72 pages Portions of This Exhibit (Indicated by “[**]”) Have Been Omitted Pursuant to Item 601(b) of Regulation S-K. Schedules and Similar Attachments to This Exhibit Have Been Omitted Pursuant to Item 601(a)(5) of Regulation S-K. Asset Purchase Agreement Dated as of 13 December 2023 Among Alkermes Pharma Ireland Limited -And- Novo Nordisk Production Ireland Limited -And- Novo Nordisk a/S
12/34/56
EX-10.5
from 10-K 30 pages Portions of This Exhibit (Indicated by “[**]”) Have Been Omitted Pursuant to Item 601(b)(10)(iv) of Regulation S-K. Schedules and Similar Attachments to This Exhibit Have Been Omitted Pursuant to Item 601(a)(5) of Regulation S-K. Development and License Agreement
12/34/56
EX-10.4
from 8-K 26 pages Transition Services Agreement by and Between Mural Oncology, Inc. and Alkermes, Inc. Dated as of November 13, 2023 Transition Services Agreement
12/34/56
EX-10.3
from 8-K 27 pages Transition Services Agreement by and Between Alkermes, Inc. and Mural Oncology, Inc. Dated as of November 13, 2023 Transition Services Agreement
12/34/56
EX-10.2
from 8-K 29 pages Employee Matters Agreement by and Between Alkermes plc and Mural Oncology PLC Dated as of November 13, 2023 1 Employee Matters Agreement
12/34/56
EX-10.1
from 8-K 37 pages Tax Matters Agreement by and Between Alkermes plc and Mural Oncology PLC Dated as of November 13, 2023 Tax Matters Agreement
12/34/56